Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers

David S. Weinberg, Nathan R. Foster, Gary Della’Zanna, Ryan P. McMurray, Walter K. Kraft, Angela Pallotto, David M. Kastenberg, Leo C. Katz, Christopher H. Henry, Stephanie M. Moleski, Paul J. Limburg, Scott A. Waldman

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers'. Together they form a unique fingerprint.

Medicine & Life Sciences